Target
Adenosine receptor A3
Ligand
BDBM204860
Substrate
n/a
Meas. Tech.
Radioligand Binding Assays
Ki
33.5±10.1 nM
Citation
 Jacobson, KAThatikonda, SKKozma, EESpalluto, GMoro, SFederico, S Fluorescent antagonists of the A3 adenosine receptor US Patent  US9227979 Publication Date 1/5/2016 
Target
Name:
Adenosine receptor A3
Synonyms:
A3 adenosine receptor (hA3) | AA3R_HUMAN | ADORA3 | Adenosine A3 receptor (A3AR)
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
36197.32
Organism:
Homo sapiens (Human)
Description:
P0DMS8
Residue:
318
Sequence:
MPNNSTALSLANVTYITMEIFIGLCAIVGNVLVICVVKLNPSLQTTTFYFIVSLALADIAVGVLVMPLAIVVSLGITIHFYSCLFMTCLLLIFTHASIMSLLAIAVDRYLRVKLTVRYKRVTTHRRIWLALGLCWLVSFLVGLTPMFGWNMKLTSEYHRNVTFLSCQFVSVMRMDYMVYFSFLTWIFIPLVVMCAIYLDIFYIIRNKLSLNLSNSKETGAFYGREFKTAKSLFLVLFLFALSWLPLSIINCIIYFNGEVPQLVLYMGILLSHANSMMNPIVYAYKIKKFKETYLLILKACVVCHPSDSLDTSIEKNSE
  
Inhibitor
Name:
BDBM204860
Synonyms:
US9227979, 8
Type:
Small organic molecule
Emp. Form.:
C19H14ClN5O2
Mol. Mass.:
379.8
SMILES:
Clc1cccc2nc(NC(=O)CCCC#C)n3nc(nc3c12)-c1ccco1
Structure:
Search PDB for entries with ligand similarity: